Lightspeed China Partners, Maotai Jianxin (Guizhou) Investment Fund, Jiayuan Capital, Yinman Venture Capital
About
Enjosim specializes in the R&D, manufacturing, and sales of self-delivery systems, particularly those for biomacromolecule pharmaceuticals. It currently sells a variety of high-precision pen injectors designed for biologics such as insulin, growth hormone, and GLP-1.
Something missing or incorrect on this page? Help us enrich this information
